-C Stephen Foster Researcher Activity Profile

Research Author Detailed Information 

C Stephen Foster Publication Rate By Year

C Stephen Foster has published 2 paper(s) in 1982, 1 paper(s) in 1984, 1 paper(s) in 2000, 21 paper(s) in 2007, 14 paper(s) in 2008, for a total of 39 research publications in total.

C Stephen Cs Foster Author Information

LAST NAME: foster

FIRST NAME: C Stephen

INITIALS: cs

AFFILIATION:

Papers

C Stephen Foster's Publication Record

1. Solitary myofibroma of the sclera. Year Published: 2007
Cogan Eye Pathology Laboratory, Department of Ophthalmology, Massachusetts Eye and Ear Infirmary (MEEI), Boston, MA, USA.
2. Punctate inner choroidopathy: a survey analysis of 77 persons. Year Published: 2007
Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
3. Pitfalls in the diagnosis of prostatic cancer: retrospective review of 1791 cases with clinical outcome. Year Published: 2007
Department of Histopathology, St Bartholomew's Hospital, London, UK. d.berney@bartsandthelondon.nhs.uk
4. Intravitreal clindamycin for toxoplasmic retinochoroiditis. Year Published: 2007
Massachusetts Eye Research and Surgery Institute, Cambridge, Massachusetts 02142, USA.
5. Tumour necrosis factor-alpha in conjunctivae affected by ocular cicatricial pemphigoid. Year Published: 2007
Massachusetts Eye Research and Surgery Institute, Cambridge, Massachusetts, USA, and Department of Ophthalmology, Hospital de Leon, Leon, Spain.
6. Relative risk for cancer in mucous membrane pemphigoid associated with antibodies to the beta4 integrin subunit. Year Published: 2007
Immunology Service, Massachusetts Eye and Ear Infirmary, Medical School, Boston, MA, USA.
7. Major shifts in the treatment and prognosis of prostate cancer due to changes in pathological diagnosis and grading. Year Published: 2007
Department of Histopathology, St Bartholomew's Hospital, Queen Mary University of London, London, UK.
8. Adamantiades-behcet disease: diagnosis and current concepts in management of ocular manifestations. Year Published: 2007
Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA.
9. The characteristic features of optical coherence tomography in posterior uveitis. Year Published: 2007
Massachusetts Eye Research and Surgery Institute, 5 Cambridge Center, 8th Floor, Cambridge, MA 02142, USA.
10. Monoclonal antibodies to the human mammary gland: III. Monoclonal antibody LICR-LON-M18 identifies impaired expression and excess sialylation of the I(Ma) cell-surface antigen by primary breast carcinoma cells. Year Published: 1984
11. Tumour necrosis factor-alpha in conjunctivae affected by ocular cicatricial pemphigoid. Year Published: 2007
Massachusetts Eye Research and Surgery Institute, Cambridge, Massachusetts, USA.
12. The characteristic features of optical coherence tomography in posterior uveitis. Year Published: 2007
Massachusetts Eye Research and Surgery Institute, 5 Cambridge Center, 8th Floor, Cambridge, MA 02142, USA.
13. Pitfalls in the diagnosis of prostatic cancer: retrospective review of 1791 cases with clinical outcome. Year Published: 2007
Department of Histopathology, St Bartholomew's Hospital, London, UK. d.berney@bartsandthelondon.nhs.uk
14. Nomogram incorporating PSA level to predict cancer-specific survival for men with clinically localized prostate cancer managed without curative intent. Year Published: 2007
Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio.
15. Tumour necrosis factor-alpha in conjunctivae affected by ocular cicatricial pemphigoid. Year Published: 2007
Massachusetts Eye Research and Surgery Institute, Cambridge, Massachusetts, USA.
16. Major shifts in the treatment and prognosis of prostate cancer due to changes in pathological diagnosis and grading. Year Published: 2007
Department of Histopathology, St Bartholomew's Hospital, Queen Mary University of London, London, UK.
17. Adamantiades-Behcet disease: diagnosis and current concepts in management of ocular manifestations. Year Published: 2007
Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA.
18. Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer. Year Published: 2008
Institute of Cancer Research, Male Urological Cancer Research Centre, Surrey, UK.
19. Tumour necrosis factor-alpha in conjunctivae affected by ocular cicatricial pemphigoid. Year Published: 2007
Massachusetts Eye Research and Surgery Institute, Cambridge, Massachusetts, USA.
20. Case records of the Massachusetts General Hospital. Case 2-2008. A 38-year-old woman with postpartum visual loss, shortness of breath, and renal failure. Year Published: 2008
Renal Division, Brigham and Women's Hospital, Boston, MA, USA.
21. Case records of the Massachusetts General Hospital. Case 2-2008. A 38-year-old woman with postpartum visual loss, shortness of breath, and renal failure. Year Published: 2008
Renal Division, Brigham and Women's Hospital, Boston, MA, USA.
22. Nomogram incorporating PSA level to predict cancer-specific survival for men with clinically localized prostate cancer managed without curative intent. Year Published: 2007
Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, USA.
23. Adamantiades-Behcet disease: diagnosis and current concepts in management of ocular manifestations. Year Published: 2007
Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA.
24. Pathology of benign prostatic hyperplasia. Year Published: 2000
Department of Cellular and Molecular Pathology, University of Liverpool, Liverpool, United Kingdom. cfoster@liv.ac.uk
25. Nomogram incorporating PSA level to predict cancer-specific survival for men with clinically localized prostate cancer managed without curative intent. Year Published: 2007
Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, USA.
26. Daclizumab for treatment of birdshot chorioretinopathy. Year Published: 2008
Massachusetts Eye Research and Surgery Institute, 5 Cambridge Center, Eighth Floor, Cambridge, MA 02142. sfoster@mersi.us.
27. Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer. Year Published: 2008
Institute of Cancer Research, Male Urological Cancer Research Centre, Surrey, UK.
28. The Boston keratoprosthesis in stevens-johnson syndrome. Year Published: 2008
Department of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts.
29. Monoclonal antibodies to the human mammary gland. I. Distribution of determinants in non-neoplastic mammary and extra mammary tissues. Year Published: 1982
30. Monoclonal antibodies to the human mammary gland. II. Distribution of determinants in breast carcinomas. Year Published: 1982
31. Diagnosis of limited ophthalmic wegener granulomatosis: distinctive pathologic features with ANCA test confirmation. Year Published: 2008
Massachusetts Eye Research & Surgery Institute, Harvard Medical School, 8th Floor, 5 Cambridge Center, Cambridge, MA, 02142, USA.
32. Diagnosis of limited ophthalmic Wegener granulomatosis: distinctive pathologic features with ANCA test confirmation. Year Published: 2008
Massachusetts Eye Research & Surgery Institute, Harvard Medical School, 8th Floor, 5 Cambridge Center, Cambridge, MA 02142, USA.
33. Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study. Year Published: 2008
Center for Preventive Ophthalmology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA. john.kempen@uphs.upenn.edu
34. Expression of cutaneous fatty acid-binding protein (C-FABP) in prostate cancer: Potential prognostic marker and target for tumourigenicity-suppression. Year Published: 2008
Molecular Pathology Laboratory, School of Cancer Studies, Faculty of Medicine, the University of Liverpool, Liverpool, L69 3GA, UK.
35. Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype. Year Published: 2008
Translational Cancer Genetics Team, Institute of Cancer Research, Surrey, UK.
36. The Boston keratoprosthesis in Stevens-Johnson syndrome. Year Published: 2008
Department of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts 02114, USA.
37. Complex patterns of ETS gene alteration arise during cancer development in the human prostate. Year Published: 2008
Institute of Cancer Research, Male Urological Cancer Research Centre, Sutton, Surrey, UK. jeremy.clark@icr.ac.uk
38. The Boston keratoprosthesis in Stevens-Johnson syndrome. Year Published: 2008
Department of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts 02114, USA.
39. Relative risk for cancer in mucous membrane pemphigoid associated with antibodies to the beta4 integrin subunit. Year Published: 2007
Immunology Service, Massachusetts Eye and Ear Infirmary, Medical School, Boston, MA, USA.